Skip to main content

Table 8 Final model for OC recurrence (A) and survival (B) for CA-125 changes 6 months after the treatment

From: Rising serum CA-125 levels within the normal range is strongly associated recurrence risk and survival of ovarian cancer

Variable Recurrence Survival
HR 95%CI P HR 95%CI P
CA-125 change < 0 U/ml 1.00 - - 1.00 - -
CA-125 change 0-5 U/ml 3.68 1.45-9.30 0.0060 1.68 0.35-8.10 0.5199
CA-125 change > 5 U/ml 19.00 6.48-55.76 0.0001 5.26 1.12-24.85 0.0360
Clear cell histology 36.15 7.40-176.66 0.0001 16.62 1.21-228.85 0.0356
FIGO stage (I&II vs III&IV) 0.14 0.05-0.41 0.0003 - - -